Loading
Impartial chair of Germany's Federal Joint Committee (G-BA), the body that decides which treatments statutory health insurance covers.
Dr. Sonja Optendrenk is the impartial chair of the Gemeinsamer Bundesausschuss (G-BA), Germany's highest decision-making body in statutory health insurance. The G-BA determines benefit coverage and commissions assessments, including early benefit assessments of new cancer drugs under AMNOG, from IQWiG. Her role is regulatory and policy leadership rather than clinical research.
Shares Gemeinsamer Bundesausschuss / IQWiG and the tags leadership, regulation, health technology assessment.
Shares the tags leadership, regulation, health technology assessment.
Shares the tags leadership, regulation, health technology assessment.
Shares the tags leadership, regulation.
Shares the tags leadership, regulation.
Shares the tags leadership, health technology assessment.
Shares the tags leadership, regulation.
Shares the tags leadership, regulation.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/